Similar Diseases
- JNA
- Intranodal palisaded myofibroblastoma
- Basal Cell Hamartoma with Follicular Differentiation
- Amphicrine adenoma
- Aggressive Papillary Tumor of the Temporal Bone
- CARCINOMA, CERUMINOUS GLAND, MALIGNANT
- Neoplasm of supraglottic part of larynx
- Lymph node palisaded myofibroblastoma
- Lymphatic vessel neoplasm
- Basicranium parasympathetic paraganglioma
Made by DATEXIS (Data Science and Text-based Information Systems) at Beuth University of Applied Sciences Berlin
Deep Learning Technology: Sebastian Arnold, Betty van Aken, Paul Grundmann, Felix A. Gers and Alexander Löser. Learning Contextualized Document Representations for Healthcare Answer Retrieval. The Web Conference 2020 (WWW'20)
Funded by The Federal Ministry for Economic Affairs and Energy; Grant: 01MD19013D, Smart-MD Project, Digital Technologies
Results for Query ‹ JNA medication/1000 ›
Nasopharyngeal angiofibroma – Treatment
Treatment for Nasopharyngeal angiofibroma (JNA) is primarily surgical. The tumor is primarily excised by external or endoscopic approach. Medical treatment and radiation therapy are only of historical interest.
External approaches:
- transpalatine approach
- transpalatine + sublabial (Sardana's) Approach
- infratemporal Approach
- nasal endoscopic Approach
- transmaxillary Approach
Endoscopic approach is an excellent tool in primary and recurrent JNA, it allows visualisation and precise removal of the lesion. Preoperative embolisation of tumour may be of some use in reducing intraoperative bleeding.
Direct visualization is not common.
Nasopharyngeal angiofibroma – Prognosis
Prognosis for nasopharyngeal angiofibroma is favorable. Because these tumors are benign, metastasis to distal sites does not occur. However, these tumors are highly vascularized and grow rapidly. Removal is important in preventing nasal obstruction and recurrent epistaxis. Mortality is not associated with nasopharyngeal angiofibroma.